FDA Approves Roche’s ENSPRYNG for Neuromyelitis Optica Spectrum Disorder (NMOSD)

NEXT STORY
OSE Immunotherapeutics Publishes Positive Preclinical COVID-19 Vaccine Results With Multi-Target Vaccine CoVepiT
PREV STORY
global market for IVD is predicted to grow at a CAGR of 5.06% over the forecast period of 2020-2030
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Second Shipment of Dried Cannabis Materials Shipped to Pharmacy Australia Centre of Excellence by PreveCeutical’s Canadian Licensed Producer Partner for Novel Nose-to-Brain Drug Delivery Research

VANCOUVER, British Columbia, May 03, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – PreveCeutical Medical ...

author_avatar
NASDAQ Market News

Roche announces FDA approval of Xofluza (baloxavir marboxil) for people at high risk of developing influenza-related complications

author_avatar
NASDAQ Market News

Iterum Therapeutics Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

author_avatar
NASDAQ Market News